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Objectives: In Switzerland, assisted suicide (AS) is legal, provided that the person seeking
assistance has decisional capacity and the person assisting is not motivated by reasons
of self-interest. However, in this particular setting nothing is known about patients’ and
their caregivers’ attitudes toward AS and life-prolonging measures. Methods: Data was
retrieved through validated questionnaires and personal interviews in 33 patients and their
caregivers covering the following domains: physical function according to the revised Amy-
otrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), demographic data, quality of
life, anxiety, depression, social situation, spirituality, burden of disease, life-prolonging, and
life-shortening acts. Results: In patients the median time after diagnosis was 9 months (2–
90) and the median Amyotrophic Lateral Sclerosis (ALS) FRS-R score was 37 (22–48). The
majority of patients (94%; n=31) had no desire to hasten death. Patients’ and caregivers’
attitudes toward Percutaneous Endoscopic Gastrostomy (PEG) and Non-InvasiveVentilation
(NIV) differed. Significantly more patients than caregivers (21.2 versus 3.1%) stated that
they were against NIV (p=0.049) and against PEG (27.3 versus 3.1%; p= 0.031). Answers
regarding tracheotomy were not significantly different (p=0.139). Caregivers scored sig-
nificantly higher levels of “suffering” (p=0.007), “loneliness” (p=0.006), and “emotional
distress” answering the questionnaires (p<0.001). Suffering (p<0.026) and loneliness
(p<0.016) were related to the score of the Hospital Anxiety and Depression Scale (HADS)
in patients. Conclusion: A liberal legal setting does not necessarily promote the wish for
AS. However, the desire to discuss AS is prevalent in ALS patients. There is a higher level
of suffering and loneliness on the caregivers’ side. A longitudinal study is warranted.
Keywords: ALS, motor neuron disease, quality of life, depression, end of life
INTRODUCTION
During the course of the disease, Amyotrophic Lateral Sclerosis
(ALS) patients may suffer from depression, hopelessness, the feel-
ing of loneliness, and loss of control (Rabkin et al., 2000, 2005;
Albert et al., 2005; Olney and Lomen-Hoerth, 2005). In the ter-
minal phase respiratory distress, anxiety, and other distressing
symptoms may occur (Mandler et al., 2001). Given the suffer-
ing associated with the disease, some patients choose to decline
life-prolonging measures such as Percutaneous Endoscopic Gas-
trostomy (PEG) and Non-Invasive Ventilation (NIV) and/or wish
to hasten death (Ganzini et al., 1998;Veldink et al., 2002; Fang et al.,
2008; Maessen et al., 2009). In an early study from Oregon, about
56% of all ALS patients considered physician-assisted suicide (PAS;
legalized after 1997) during the terminal phase and 73% of care-
givers and patients had similar attitudes toward PAS (Ganzini et al.,
1998). In the Netherlands, during the 2000–2005 period 16.8% of
ALS patients decided for euthanasia or PAS (Maessen et al., 2009),
while in Sweden (where PAS is not legalized), ALS patients have
a sixfold increased risk of committing suicide (Fang et al., 2008).
Factors such as depression, hopelessness, loss of meaning, and
purpose in life have been discussed to be associated with the wish
to hasten death, whereas the contrary applies to religious faith
and spiritual beliefs (Rabkin et al., 2000, 2005; Albert et al., 2005;
Olney and Lomen-Hoerth, 2005). These findings are not consis-
tent between different countries (Maessen et al., 2009). Moreover,
there is a lack of longitudinal studies analyzing changes of these
factors over time. It is also unclear whether the legal background
in different countries influences patients’ attitudes toward assisted
suicide (AS) as comparative studies are lacking.
In Switzerland, however, assistance in committing suicide by
a physician or a lay person is not explicitly regulated by law, but
article 115 of the Swiss Penal Code allows assistance in suicide
provided that the person seeking assistance has decisional capac-
ity and the person assisting – physician or lay person – is not
motivated by reasons of self-interest. Based on this article, Swiss
“right to die”organizations offer assistance to commit suicide (Fis-
cher et al., 2008). A recent study from the City of Zurich revealed
that between 2001 and 2004 “Dignitas or Exit Deutsche Schweiz”
had facilitated a total of 421 cases of AS (Fischer et al., 2008).
Amongst the patients, 60% had been non-residents in Switzerland
emphasizing the problem of “suicide tourism.” Twenty-four per-
cent of ASs were patients with “neurological disorders” including
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ALS. However, no information is available about the total number
of ALS patients, their motivation and associated factors that had
made them choose this exit strategy.
The objective of this study is to analyze patients’ and caregivers’
attitudes toward AS, life-prolonging measures as well as associated
factors (e.g., depression, quality of life (QoL), loneliness, suffering,
education, profession, family status, living situation, Amyotrophic
Lateral Sclerosis Functional Rating Scale (ALSFRS, and time after
diagnosis) in a country with a comparatively easy access to AS.
METHODS AND PARTICIPANTS
PARTICIPANTS
Swiss patients and their primary caregivers were recruited from a
tertiary referral center (Muskelzentrum/ALS clinic) at the Kanton-
sspital St. Gallen. Patients and caregivers attended the ALS outpa-
tient clinic on a regular basis (usually every 3 months). Patients and
caregivers had to be at least 18 years old. Further inclusion criteria
for patients were a diagnosis of definitive, probable, or proba-
ble laboratory supported ALS according to the revised El Escorial
Criteria (Brooks et al., 2000). Patients were only eligible if they
had been informed about their ALS diagnosis, disease progression,
prognosis, and therapeutic options including PEG insertion and
different forms of ventilation (e.g., NIV, tracheotomy). The discus-
sion about PEG and ventilation was usually triggered by clinical
decline that resulted in use of PEG or NIV. Both issues are part
of ALS – specific advanced directives which are routinely applied
during this discussion (Benditt et al., 2001). Patients who inquired
about these interventions shortly after diagnosis were also eligi-
ble. The study was approved by the local ethics committee and all
patients and caregivers gave written informed consent.
For this study inclusion criteria, exclusion criteria, variables,
and statistical analysis were pre-specified. Data were retrieved
through questionnaires and personal interviews during home vis-
its. The data collection took place as soon as patients had been
informed about life-prolonging measures. Interviews were carried
out by a researcher trained in interview technique, experienced
in pastoral care, and medical ethics, not involved in clinical care
of the patients and their primary caregivers. Patients and care-
givers filled in the questionnaires simultaneously. In case the
patient was unable to complete the questionnaire by his/her own
hand due to weakness, the interviewer completed the question-
naire according to the patient’s statements. The mean duration
of the interview was approximately 60 min. After the interview,
the primary caregiver/relative had the opportunity to clarify any
issues that may have arisen during completion of the question-
naire. Specifically the following data and questionnaires were
retrieved/applied:
Demographic data
The collection of data included age, sex, living situation, education,
profession, and religious confession.
Numerical rating scale
(Eleven-point format; 0–10) asking the following questions: (1)
What is your current QoL?; (2) How much are you suffering from
your disease/from the disease of your partner?; (3) How lonely do
you feel?; (4) How strong is your current desire to ask others for
help to end your life prematurely?; (5) How distressing or how
helpful was it for you to speak about such issues?
Hospital anxiety and depression scale (HADS)
A self-assessment scale to quantify patients’ anxiety and depression
by choosing one response from four given. The range is from 0 to
42 with the maximum score indicating a high level of depression
and anxiety (Bjelland et al., 2002).
Questions regarding life-prolonging measures and hastening death
Patients’ and caregivers’ opinions were assessed with regards to
tracheotomy, NIV, and PEG within a four-point response format.
The following questions were asked: What is your attitude toward
the following life-prolonging measures: (a) Tracheotomy; (b) NIV;
(c) PEG? Possible answers to each item were: (a) I am not sure; (b)
I am absolutely in favor of it; (c) I am in favor of it under certain
circumstances; (d) I am against it.
Questions in yes/no format included: (1) Have you ever thought
about committing suicide after receiving your diagnosis?; (2) Can
you imagine a future scenario in which a physician prescribes a
fatal drug which you administer yourself?; (3) Can you imagine a
future scenario in which a physician prescribes and administers to
you a fatal drug?; (4) Have you ever discussed suicide with others?;
(5) Would you like to discuss suicide with a physician?
Idler index of religiosity (IRR)
The IRR assesses both public and private religiosity: (1) summing
up attendance at religious meetings and services and the number
of church members known to the patient; (2) self-assessment of
personal religiosity as well as the amount of strength and comfort
provided by personal faith (Robbins et al., 2001).
STATISTICAL ANALYSIS
For continuous variables (e.g., age) the mean of the differences
between “patient” and “caregiver” was calculated by the t -test.
Variables applying scores were compared by the Wilcoxon signed
rank tests providing the median difference and its 95% confidence
limits. Differences of ordered categorical variables (four-point
response format) were tested by the Fishers exact test and the
McNemar’s Chi-squared test. For analyzing possible associations
between the paired samples (“patient,”“caregiver”) the Spearman’s
rho correlation coefficient was applied. The level of significance
was p< 0.05.
In order to predict score ratios between patients and caregiver,
generalized linear mixed-effects models with group (“patient” and
“caregiver”) and given variables as fixed factors (sex, age, educa-
tion, profession, family status, living situation, children, ALSFRS,
time after diagnosis, and QoL) and subject (“patient”) as ran-
dom factor were performed either as multivariate or univariate
model (for each parameter as a separate model). In order to pre-
dict dichotomous variables (yes versus no) concerning suicidal
ideation for patients, logistic regression models were performed
providing odds ratios (OR) and 95% confidence intervals (CI)
with corresponding p-values.
All analyses were performed using R version 2.12.2 (R Devel-
opment Core Team, 2011).
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RESULTS
DEMOGRAPHIC DATA
During the recruitment period from 2008 to 2010 a total of 59
patients and caregivers were asked whether they would partici-
pate in this study. Twenty-six patients declined, 33 patients and
their caregivers agreed to participate. The most frequent reason
for declining participation was“no interest”and reluctance toward
the themes of religiosity and spirituality. Table 1 summarizes the
epidemiological data, social status, and religious denominations
of patients and their caregivers. Mean age of patients was 59.6 and
mean age of caregivers was 56.9 (paired t -test; p= 0,065). The
median time after diagnosis at which the first interview took place
was 9 months (2–90) and the median ALSFRS-R was 37 (22–48).
ASSISTED SUICIDE/HASTENING DEATH
Thirteen patients (39%) answered that during the course of the
disease they had thought about the possibility of committing
suicide (Table 2). However, at the time of the interview, 31 of
the patients (94%) expressed no wish to hasten death by AS.
Thirty-three percent of the patients would like to discuss the issue
“suicide” with a physician. Fifty-four percent of the patients could
imagine asking a physician in the future to prescribe a fatal drug
that they could take themselves; 57% could imagine a physician
administer such a drug to them in the future. Logistic regression
revealed that for patients QoL was the major predictor toward sui-
cidal ideation (OR: 0.58, CI: 0.35–0.99) and the wish to discuss
suicide with a physician (OR: 0.32, CI: 0.13–0.81, Table 2). The
number of children (OR: 0.54, CI: 0.28–1.04) and HADS score
(OR: 1.2, CI: 0.99–1.45) was also predictive of the wish to dis-
cuss suicide with a physician. Other analyzed factors (education,
profession, family status, living situation, ALSFRS, and time after
diagnosis) were not associated.
LIFE-PROLONGING MEASURES
The majority of patients (57.6%) and caregivers (50.0%) were
against tracheotomy (Table 3). As verified by the McNemar test
no significant difference was detected between the coincident
answers of the two study groups (p= 0.37). No patient and no
caregiver were generally in favor of its application, only“under cer-
tain circumstances” (27.3 patients versus 25.0% caregivers). The
Table 1 | Demographic data.
Patients % (n) Caregivers % (n)
Age (mean, range) 59.6 (38–79) 56.9 (31–79)
Sex
Female 36.4 (12) 62.5 (20)
Male 63.6 (21) 37.5 (12)
Living situation
Alone 9.1 (3) 3.1 (1)
With spouse 57.6 (19) 59.4 (19)
With spouse and child(ren) 33.3 (11) 37.5 (12)
Religious confession
Roman-catholic 51.5 (17) 46.9 (15)
Protestant 33.3 (11) 25.0 (8)
No confession 15.2 (5) 28.1 (9)
remaining interviewees were “unsure” about tracheotomy. Within
the four-point response format attitudes between patients and
caregivers regarding NIV and PEG differed (Fishers exact test). Sig-
nificantly more patients than caregivers (21.2 versus 3.1%) stated
that they were against NIV (p= 0.049) and against PEG (27.3
versus 3.1%; p= 0.031).
QUALITY OF LIFE AND BURDEN OF DISEASE
The median of QoL rated on a 11-point scale was six for patients
and caregivers (p= 0.68). “Suffering,” “loneliness,” and “emo-
tional distress answering the questionnaire” were significantly
higher on the caregivers’ than on the patients’ side (Table 4). The
mean HADS score of patients was 10.6± 5.1. Univariate analy-
sis by a general linear mixed-effects model revealed a significant
influence of the HADS on “suffering” (OR: 1.04 (95% CI: 1.01–
1.07, p= 0.027) and “loneliness” (OR: 1.17 (95% CI: 1.04–1.33,
p= 0.017) for coincident answers of patients and caregivers. Other
analyzed factors (sex, age, education, profession, family status,
living situation, children, ALSFRS-R, time after diagnosis, and
QoL) did not show a significant effect, both in univariate and
multivariate analysis (data not shown).
RELIGIOSITY
With regard to publicly practiced or private religiosity patients
considered themselves to be more religious than their caregivers
(p< 0.001) and derived more strength and comfort from their
faith (p< 0.01).
DISCUSSION
The most important finding of the study is that at the time of the
interview 94% of the patients had no intention to hasten death.
This seems notable as the Swiss legal situation is liberal regard-
ing assistance to commit suicide and the society is tolerating the
practice of lay organizations offering the assistance through the
collaboration of physicians and lay persons (van der Heide et al.,
2003; Reiter-Theil, 2006). In contrast, a comparable study from
Germany on ALS patients revealed that 37% of patients wished
to hasten death (Jox et al., 2007). Germany is characterized by
a liberal regulation of AS in penal law, but at the same time by
a restrictive regulation and prohibition of PAS in the medical
law (Reiter-Theil, 2006). The only difference between the Swiss
and the German study methodology was that our patients were
interviewed at home, whereas in the German study the interviews
took place in the outpatient clinical. This difference, however, is
unlikely to account for the imbalance and suggests that not the legal
background as such (e.g., a more liberal legal situation promotes
AS), but other factors must be responsible for the wish to hasten
death. Previous studies from Oregon and the Netherlands where
PAS is also legal, revealed a high prevalence of AS and euthana-
sia among ALS patients (Ganzini et al., 1998, 2002; Veldink et al.,
2002; Albert et al., 2005; Maessen et al., 2009). This contrasts with
our findings where only a minority of patients expressed a wish
to hasten death. However, a comparison of our results with the
Oregonian and Dutch studies is difficult as they were either retro-
spective (Veldink et al., 2002; Maessen et al., 2009) or interviews
took place at a late to terminal stage (Ganzini et al., 2002; Albert
et al., 2005). Longitudinal studies analyzing attitudes toward AS
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Table 2 | Patient suicidality; n.s., no significant effect.
Yes % (n) No % (n) No answer % (n) Associated factors (adjusted for gender and age)
Thought about suicide after receiving diagnosis 39.4 (13) 60.6 (20) 0 n.s.
Can imagine future scenario: committing suicide
by means of a prescribed drug
54.5 (18) 45.5 (15) 0 Quality of life (p=0.026)
Can imagine future scenario: suicide with the
help of physician administering fatal drug
57.6 (19) 42.4 (14) 0 n.s.
Have already discussed suicide with others 33.3 (11) 66.7 (22) 0 n.s.
Would like to discuss suicide with a physician 33.3 (11) 60.6 (20) 6.1 (2) Number of children (p=0.048), quality of life
(p<0.001), HADS (p=0.037)
Table 3 | Live-prolonging measures: “what is your attitude toward the following life-prolonging measures?” p-values derived from McNemar
test.
Not sure% (n) Absolutely yes % (n) Yes under certain
circumstances % (n)
Against % (n) p
Tracheotomy 0.37
Patients 15.2 (5) 0 27.3 (9) 57.6 (19)
Caregivers 25.0 (8) 0 25 (8) 50.0 (16)
NIV 0.17
Patients 3.0 (1) 42.4 (14) 33.3 (11) 21.2 (7)
Caregivers 18.8 (6) 43.8 (14) 34.4 (11) 3.1 (1)
PEG 0.75
Patients 12.1 (4) 24.2 (8) 36.4 (12) 27.3 (9)
Caregivers 25.0 (8) 18.8 (6) 53.1 (17) 3.1 (1)
Table 4 | Quality of life and burden of disease variables rated on self-rating scales (0–10).
Parameters Patients (median, IQR) Caregivers (median, IQR) Difference of medians Lower 95% CI Upper % 95 CI p-value
Quality of life 6 (5–8) 6 (5–7) 0.25 −1.0 1.5 0.68
Loneliness 0 (0–1) 2 (0–6) −3.25 −5.5 −1.5 0.003
Emotional distress 0 (0–1) 3 (0.8–5) −4.25 −5.5 −3.0 <0.001
Suffering 5 (3–6) 6.5 (5–8) −2.25 −3.5 −0.5 0.006
Differences determined byWilcoxon signed rank test. IQR, inter quartile range.
have not been published yet, but are important to understand
whether these attitudes depend on the degree of disability.
With respect to preferences for life-prolonging and ameliorative
technologies it seems that ALS patients make choices consistent
with preferences expressed shortly after diagnosis (Albert et al.,
1999). It is unclear whether this also applies to attitudes toward
AS. Nevertheless, more than one-third (39%) of our patients had
thought about the possibility of committing suicide after being
diagnosed with ALS and 33% of the patients expressed the wish
to discuss suicide with their physician. Even 58% said they could
imagine a future scenario in which a physician would not only
prescribe, but also administer a fatal drug (i.e., euthanasia which
is prohibited in Switzerland) to them. This mirrors other studies
which have shown that the themes of assisted dying and suicide are
prevalent in ALS patients (Ganzini et al., 1998, 2002; Albert et al.,
2005; Palmieri et al., 2010). The wish of patients to discuss sui-
cide with a physician was associated with poorer QoL and a higher
HADS score. It can be concluded that medical caregivers need to
develop an openness and willingness to discuss with and inform
patients about suicide and to deal with the fact that a considerable
number of patients facing end of life may ask for their physician’s
active involvement in hastening death (Bascom and Tolle, 2002;
Jox et al., 2007; Moore et al., 2007; Oliver et al., 2007). The preva-
lence for a physician’s active involvement in hastening death in
the future corresponds with a retrospective study (Lofmark et al.,
2008) which reports that 37% of the Swiss physicians (n= 1397)
had received a patient request to hasten death.
Patients’ and caregivers’ attitudes regarding life-prolonging
measures were largely concordant. Fifty-eight percent of patients
and 50% of caregivers were against tracheotomy. However,
caregivers (mean: 22.2%) in general were considerably more
unsure about NIV, PEG, and tracheotomy than patients
(mean: 9.8%). Furthermore significantly more patients than
caregivers were strictly against PEG and NIV. This con-
firms a fundamental need for more information and dis-
cussion about life-prolonging measures as has also been
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shown by other studies (Albert et al., 1999; Trail et al.,
2003).
Another important finding of this study is that caregivers scored
significantly higher in the domains of suffering, loneliness, and dis-
tress filling out the questionnaires compared to patients, despite
overall QoL being not different between patients and their care-
givers. The only associated factor was patients’ depression and
anxiety as measured by HADS. Sex, age, education, profession,
family status, living situation, children, ALSFRS, time after diag-
nosis, and QoL were not related. Previous studies also revealed that
depression in patients is associated with caregiver burden (Chio
et al., 2005) and that patients’ and caregivers’ well-being are inter-
related (Pagnini et al., 2011). Other examined factors such as time
since diagnosis and degree of disability were not related in our as
in previous studies (Rabkin et al., 2000; Chio et al., 2005). This is
in contrast with studies that have shown that caregiver burden and
distress are associated with the degree of disability (Hecht et al.,
2003; Chio et al., 2005; Lo Coco et al., 2005). However, it needs to
be taken into account that the patients in our study had only mild
to moderate handicap as compared to other studies. A prospective
longitudinal study may help to resolve this discrepancy and would
also reveal dynamic changes as disease and disability progress.
This study has several limitations. Patients were recruited from
a single center and may therefore not be representative for all Swiss
ALS patients. At our ALS Clinic patient care is strictly adhering to
international guidelines (Miller et al., 2009; Andersen et al., 2012)
which may not be the case in all Swiss centers. Each follow-up
consultation lasts 2 h allowing ample time to discuss end of life
decisions and related issues that may have influenced the results.
Second, since spirituality and religiosity were part of the study,
this may have introduced a self-selection bias toward couples that
tend to be more religious which is known to be inversely related
to the wish to hasten death (Albert et al., 2005). The themes of
religiosity/spirituality may also contribute for the relatively high
non-participate rate of 44%. However, these problems are inherent
in almost all of the published interview studies.
CONCLUSION
In summary the “liberal” Swiss legal setting does not promote the
wish for AS, but the wish to discuss AS is prevalent amongst ALS
patients even in moderately advanced stages of the disease. This
wish is associated with poorer QoL and degree of depression.
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